You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 503 KH-801, a differentated humanized anti-CD24 antibody, potentiates the effects of immunomodulatory and anti-tumor activity in preclinical cancer models with favorable safety profiles

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
503 KH-801, a differentated humanized anti-CD24 antibody, potentiates the effects of immunomodulatory and anti-tumor activity in preclinical cancer models with favorable safety profiles

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023396039
Dec 202391015
Jan 202448010
Feb 20245606
Mar 20247804
Apr 2024126018
May 202496015
Jun 2024118010
Jul 2024144020
Aug 202490018
Sep 2024142013
Oct 202488018
Nov 202476015
Dec 202444017
Jan 202588020
Feb 2025208
Mar 20250013
Apr 2025009
May 20250013
Jun 20250011
Total16830292